Apriso
Apriso is a locally acting aminosalicylate (5-ASA) anti-inflammatory drug. It is specifically formulated as an extended-release capsule to deliver mesalamine to the colon, helping to maintain remission of ulcerative colitis in patients 18 years of age and older.
Dosage by Body Weight
The recommended dose for adult patients is 1.5 g (four 0.375 g capsules) taken once daily in the morning. Apriso capsules can be taken with or without food. Do not chew, crush, or break the capsules, as this disrupts the extended-release formulation.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Apriso in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Apriso in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Apriso in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Apriso in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- N/A
- Tracking Notes
- Safety and effectiveness of Apriso in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | N/A | Safety and effectiveness of Apriso in pediatric patients have not been established. |
| 5-7 kg | Not recommended | N/A | Safety and effectiveness of Apriso in pediatric patients have not been established. |
| 8-10 kg | Not recommended | N/A | Safety and effectiveness of Apriso in pediatric patients have not been established. |
| 11-15 kg | Not recommended | N/A | Safety and effectiveness of Apriso in pediatric patients have not been established. |
| 16-20 kg | Not recommended | N/A | Safety and effectiveness of Apriso in pediatric patients have not been established. |
Formulation
Extended-Release Capsule
Purpose
Maintenance of remission of ulcerative colitis in adults.
Generic Name
MesalamineScheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.